Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Janssen Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Janssen Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3291679Altering Microbial Populations & Modifying MicrobiotaSNIPRSep 14, 2022
EP2588167Safety Device For A Pre-Filled Syringe And Injection DeviceSANOFI AVENTIS DEUTSCHLANDNov 21, 2018

Explore Janssen Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3744326Dec 6, 2023Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters9
EP3280416Apr 22, 2020Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters8